Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationMyelodysplastic SyndromesTransplantation, HomologousTransplantation, AutologousBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorLeukapheresisHematologic NeoplasmsHematopoietic Stem CellsStem CellsAntigens, CD34Blood Component RemovalTreatment OutcomeStem Cell TransplantationTissue DonorsImmunosuppressive AgentsMelphalanGraft SurvivalCombined Modality TherapyAnemia, RefractoryAnemia, Refractory, with Excess of BlastsLeukemia, Myeloid, AcuteCyclophosphamideBusulfanAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaCord Blood Stem Cell TransplantationBlood Cell CountRecurrenceSyndromeBlood CellsLeukemiaBone MarrowLymphoma, Non-HodgkinHistocompatibilityMyeloablative AgonistsBlood DonorsRemission InductionAnemia, AplasticHistocompatibility TestingRetrospective StudiesLeukemia, MyeloidHematopoiesisLeukemia, Myelomonocytic, ChronicWhole-Body IrradiationAntineoplastic Agents, AlkylatingEtoposideCytomegalovirus InfectionsSurvival RateVidarabineSurvival AnalysisTime FactorsTransplantation ChimeraBone Marrow CellsAcute DiseaseDisease-Free SurvivalHematologic DiseasesCytarabineThiotepaBone Marrow DiseasesSalvage TherapyInfectionFlow CytometryPlatelet CountOpportunistic InfectionsPrognosisImmunocompromised HostTransplantationBone Marrow PurgingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunophenotypingFatal OutcomeChromosomes, Human, Pair 5Hodgkin DiseaseNeoplasmsFollow-Up StudiesIfosfamideRecombinant ProteinsLeukocytes, MononuclearEmbryonic Stem CellsLeukocyte CountThalidomideCell SeparationCyclosporineLymphomaNeutropeniaAntineoplastic AgentsProspective StudiesAzacitidinePlatelet TransfusionColony-Forming Units AssayLeukocyte TransfusionPOEMS SyndromePrecursor Cell Lymphoblastic Leukemia-LymphomaAdult Stem CellsT-Lymphocytes